Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SMBS
Schwab Mortgage-Backed Securities ETF
SMBS
|
+$5.08B |
| 2 |
Schwab Municipal Bond ETF
SCMB
|
+$1.29B |
| 3 |
Schwab US Large-Cap Growth ETF
SCHG
|
+$752M |
| 4 |
Microsoft
MSFT
|
+$699M |
| 5 |
NVIDIA
NVDA
|
+$578M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Mortgage-Backed Securities ETF
VMBS
|
+$4.9B |
| 2 |
Invesco FTSE RAFI US 1000 ETF
PRF
|
+$986M |
| 3 |
iShares National Muni Bond ETF
MUB
|
+$951M |
| 4 |
Invesco FTSE RAFI US 1500 Small-Mid ETF
PRFZ
|
+$794M |
| 5 |
Schwab Fundamental International Small Company Index ETF
FNDC
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.55% |
| 2 | Financials | 11.83% |
| 3 | Healthcare | 9.33% |
| 4 | Consumer Discretionary | 9.25% |
| 5 | Industrials | 8.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3476
TScan Therapeutics
TCRX
$50.1M
| $32.1K | ﹤0.01% |
22,171
-90,770
| -80% | -$131K |
|
3477
Phunware
PHUN
$41.7M
| $31.7K | ﹤0.01% |
10,000
| – | – |
|
3478
1stdibs.com
DIBS
$153M
| $30.1K | ﹤0.01% |
10,941
-55,361
| -83% | -$143K |
|
3479
LiveOne
LVO
$60.4M
| $30K | ﹤0.01% |
3,979
-18,129
| -82% | -$135K |
|
3480
Solitario Resources
XPL
$72.2M
| $29.2K | ﹤0.01% |
44,899
| – | – |
|
3481
RAVE Restaurant Group
RAVE
$43.9M
| $27.5K | ﹤0.01% |
10,012
| – | – |
|
|
NOTV
3482
DELISTED
Inotiv
NOTV
| $27.3K | ﹤0.01% |
15,000
| – | – |
|
3483
Rekor Systems
REKR
$91.2M
| $25.5K | ﹤0.01% |
22,007
-186,080
| -89% | -$195K |
|
3484
Veritone
VERI
$134M
| $25.2K | ﹤0.01% |
20,000
| – | – |
|
3485
Inovio Pharmaceuticals
INO
$76.1M
| $24.4K | ﹤0.01% |
12,013
-86,482
| -88% | -$166K |
|
3486
Bridger Aerospace
BAER
$80.6M
| $24.1K | ﹤0.01% |
12,500
-20,501
| -62% | -$31.5K |
|
3487
Ocean Power Technologies
OPTT
$50.5M
| $23.7K | ﹤0.01% |
50,000
| – | – |
|
3488
Milestone Scientific
MLSS
$42M
| $21.9K | ﹤0.01% |
34,400
| – | – |
|
3489
Adicet Bio
ACET
$75.9M
| $18.3K | ﹤0.01% |
1,875
| – | – |
|
3490
Heartbeam
BEAT
$30.5M
| $18.2K | ﹤0.01% |
14,543
| – | – |
|
3491
Immunic
IMUX
$192M
| $17.4K | ﹤0.01% |
2,500
| – | – |
|
3492
Shattuck Labs
STTK
$682M
| $16.6K | ﹤0.01% |
20,906
-93,233
| -82% | -$90.4K |
|
3493
ClearSign Technologies
CLIR
$26.6M
| $13.7K | ﹤0.01% |
2,556
| – | – |
|
|
RVPH
3494
DELISTED
REVIVA PHARMA HLDGS INC
RVPH
| $5.72K | ﹤0.01% |
750
| – | – |
|
3495
Acumen Pharmaceuticals
ABOS
$176M
| – | – |
-116,902
| Closed | -$129K |
|
3496
Achieve Life Sciences
ACHV
$685M
| – | – |
-89,562
| Closed | -$239K |
|
|
ADVM
3497
DELISTED
Adverum Biotechnologies
ADVM
| – | – |
-49,024
| Closed | -$214K |
|
|
AKYA
3498
DELISTED
Akoya BioSciences
AKYA
| – | – |
-63,026
| Closed | -$87.6K |
|
3499
Aemetis
AMTX
$120M
| – | – |
-85,177
| Closed | -$148K |
|
3500
Actinium Pharmaceuticals
ATNM
$24.2M
| – | – |
-97,604
| Closed | -$157K |
|
Similar funds
Charles Schwab's Q2 2025 Portfolio in Review
As of Q2 2025, Charles Schwab held 3,631 positions worth $578B, up 8.5% from $533B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Charles Schwab's Q2 2025 filing shows 158 new, 2,252 increased, 1,020 reduced and 137 closed positions. Its largest new stake was Schwab Mortgage-Backed Securities ETF: 202,020,489 shares worth $5.15B. The largest sale was Vanguard Mortgage-Backed Securities ETF, an estimated $4.9B.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q2 2025 buy was Schwab Mortgage-Backed Securities ETF: 202,020,489 shares worth $5.15B.
- Charles Schwab added most to Schwab Municipal Bond ETF in Q2 2025, an estimated $1.29B increase.
- Charles Schwab's biggest Q2 2025 reduction was Vanguard Mortgage-Backed Securities ETF, cutting an estimated $4.9B.
- Charles Schwab fully exited Invesco FTSE RAFI US 1000 ETF in Q2 2025, selling an estimated $986M.
- Charles Schwab's ten largest holdings make up 23% of its $578B portfolio in Q2 2025.
- Charles Schwab opened 158 new positions and closed 137 in Q2 2025.
- Charles Schwab's portfolio value rose 8.5% quarter-over-quarter to $578B.
Based on Charles Schwab's 13F filing for Q2 2025, filed 12 Aug 2025.